Company
Liebel-Flarsheim
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
10
4 still marketed
Novel approvals
3
Approvals since 2021
0
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Optimark In Plastic Container new use Aug 4, 2006
- Optimark new use Aug 4, 2006
- Optimark new use Aug 4, 2006
- Sodium Chloride 0.9% In Plastic Container approved Jul 27, 2006
- Optimark In Plastic Container new use Jan 31, 2003
- Optimark new use Jan 31, 2003
- Optimark new use Jan 31, 2003
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (4)
Newest FDA action first.
- Optiray 300 Ioversol · 1998
- Optiray 350 Ioversol · 1988
- Sodium Chloride 0.9% In Plastic Container Sodium Chloride · 2006
- Cysto-Conray Ii Iothalamate Meglumine · 1972
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.